ROSE Diagnostics

Carlsbad, CA · Founded 2023 · Privately Held (backing)

Developer of lymph biomarkers designed for cancer diagnostics. ROSE Diagnostics is based in Carlsbad, CA and was founded in 2023. It has raised $3.4 million across 2 recorded rounds; the latest was a $2.3 million seed round in May 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$3.4M
Last round
Seed Round
May 2025
Cap table — not yet on record

ROSE Diagnostics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of ROSE Diagnostics with a free Private Market View account
  • ·Watch ROSE Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about ROSE Diagnostics

Where does ROSE Diagnostics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ROSE Diagnostics's 2 recorded funding rounds.